drug protocol number

113780

drug sponsor

GSK

drug study

Lapatinib / Capecitabine

drug trial site

King Abdulaziz Medical City NG (Riyadh) , King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Hospital and Oncology Center (Jeddah)

drug status

Ongoing

drug phase